WA
RMTI icon

WealthTrust Axiom’s Rockwell Medical RMTI Stock Holding History

WealthTrust Axiom’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Sell
3,300
-610
-16% -$4.83K ﹤0.01% 302
2026
Q1 		$34.9K Buy
3,910
+120
+3% +$1.2K 0.01% 288
2025
Q4 		$31.6K Buy
3,790
+720
+23% +$7.27K 0.01% 272
2025
Q3 		$36.8K Sell
3,070
-1,680
-35% -$20.5K 0.01% 269
2025
Q2 		$40.3K Buy
4,750
+800
+20% +$8.16K 0.01% 258
2025
Q1 		$44.6K Buy
3,950
+50
+1% +$907 0.01% 249
2024
Q4 		$79.6K Buy
3,900
+100
+3% +$2.92K 0.02% 244
2024
Q3 		$151K Buy
3,800
+650
+21% +$17.5K 0.04% 245
2024
Q2 		$55.4K Hold
3,150
– – 0.02% 244
2024
Q1 		$52.3K Hold
3,150
– – 0.02% 251
2023
Q4 		$59.5K Buy
3,150
+1,040
+49% +$19.5K 0.02% 241
2023
Q3 		$43.9K Buy
+2,110
New +$64.1K 0.02% 233
2016
Q4 		– Sell
-119
Closed -$87K – 233
2016
Q3 		$87K Sell
119
-2
-2% -$1.62K 0.03% 212
2016
Q2 		$100K Buy
+121
New +$113K 0.04% 210

Other funds holding RMTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WealthTrust Axiom's RMTI Position: Q2 2026 in Review

WealthTrust Axiom reduced its Rockwell Medical (RMTI) stake by 16% in Q2 2026, selling an estimated $4.83K and leaving 3,300 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

WealthTrust Axiom first reported a position in RMTI in Q2 2016 and has held it in 14 quarters since. The position peaked at $151K in Q3 2024. 37 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

  • WealthTrust Axiom held 3,300 shares of Rockwell Medical worth $18.2K as of Q2 2026.
  • WealthTrust Axiom sold 610 Rockwell Medical shares in Q2 2026, an estimated $4.83K.
  • Rockwell Medical made up ﹤0.01% of WealthTrust Axiom's portfolio in Q2 2026, its #302 holding.
  • WealthTrust Axiom first reported a position in Rockwell Medical in Q2 2016 and has held it in 14 quarters since.
  • WealthTrust Axiom's Rockwell Medical position peaked at $151K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on WealthTrust Axiom's 13F filing for Q2 2026, filed 11 Aug 2026.